Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canakinumab in Knee Osteoarthritis
NCT01160822Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2010
- Primary completion
- Jul 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of canakinumab in osteoarthritis (OA), sponsored by Novartis. Started Apr 2010; status: completed.
02
Drugs
canakinumab
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01160822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01160822.